Tenax Therapeutics Ownership 2024 | Who Owns Tenax Therapeutics Now?

Overview RevenueFinancials Chart

Institutional Ownership

0.00%

Insider Ownership

0.36%

Institutional Holders

1.00

Tenax Therapeutics Institutional Shareholders

Institutional Shareholders by % of Total Shares

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
CI PRIVATE WEALTH, LLC	13.62%	0.00%	191,460	191,460	100.00%	89,029,000	Mar 31, 2023
STATE STREET CORP	6.77%	-	95,122	95,122	100.00%	44,232,000	Mar 31, 2023
VIRTU FINANCIAL LLC	6.00%	0.00%	84,361	84,361	100.00%	39,000	Mar 31, 2023
VERITION FUND MANAGEMENT LLC	3.10%	0.00%	43,579	43,579	100.00%	20,264,000	Mar 31, 2023
TWO SIGMA SECURITIES, LLC	3.06%	0.00%	42,995	42,995	100.00%	19,993,000	Mar 31, 2023
BLACKROCK INC.	1.70%	-	23,922	23,922	100.00%	11,124,000	Mar 31, 2023
AVANTAX PLANNING PARTNERS, INC.	0.71%	0.00%	10,002	10,002	100.00%	4,651,000	Mar 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)	0.33%	0.00%	4,697	4,697	100.00%	2,000	Mar 31, 2023
MORGAN STANLEY	0.05%	-	680	680	100.00%	316,000	Mar 31, 2023
WELLS FARGO & COMPANY/MN	0.00%	-	64	64	100.00%	30,000	Mar 31, 2023
TUCKER ASSET MANAGEMENT LLC	0.00%	-	2	2	100.00%	1,000	Mar 31, 2023
ALLWORTH FINANCIAL LP	0.00%	-	1	1	100.00%	1,000	Mar 31, 2023
WELLS FARGO & COMPANY/MN	-	-	-	-13	-100.00%	-	Mar 31, 2023
UBS GROUP AG	-	-	-	-8,049	-100.00%	-	Mar 31, 2023
BLACKROCK INC.	-	-	-	-23,954	-100.00%	-	Mar 31, 2023
NORTHERN TRUST CORP	-	-	-	-1,734	-100.00%	-	Mar 31, 2023
MORGAN STANLEY	-	-	-	-680	-100.00%	-	Mar 31, 2023
STATE STREET CORP	-	-	-	-6,921	-100.00%	-	Mar 31, 2023
RENAISSANCE TECHNOLOGIES LLC	-	-	-	-3,169	-100.00%	-	Mar 31, 2023
ACADIAN ASSET MANAGEMENT LLC	-	-	-	-60,501	-100.00%	-	Mar 31, 2023

Tenax Therapeutics's largest institutional shareholder is CI PRIVATE WEALTH, LLC, holding 13.62% of the company's total share outstanding, currently valued at $89.03M. The top 10 institutional shareholders own together 35.34% of the company.

Institutional Shareholders by % of Total Assets

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
VIRTU FINANCIAL LLC	6.00%	0.00%	84,361	84,361	100.00%	39,000	Mar 31, 2023
TWO SIGMA SECURITIES, LLC	3.06%	0.00%	42,995	42,995	100.00%	19,993,000	Mar 31, 2023
VERITION FUND MANAGEMENT LLC	3.10%	0.00%	43,579	43,579	100.00%	20,264,000	Mar 31, 2023
CI PRIVATE WEALTH, LLC	13.62%	0.00%	191,460	191,460	100.00%	89,029,000	Mar 31, 2023
AVANTAX PLANNING PARTNERS, INC.	0.71%	0.00%	10,002	10,002	100.00%	4,651,000	Mar 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)	0.33%	0.00%	4,697	4,697	100.00%	2,000	Mar 31, 2023
STATE STREET CORP	6.77%	-	95,122	95,122	100.00%	44,232,000	Mar 31, 2023
BLACKROCK INC.	1.70%	-	23,922	23,922	100.00%	11,124,000	Mar 31, 2023
TUCKER ASSET MANAGEMENT LLC	0.00%	-	2	2	100.00%	1,000	Mar 31, 2023
MORGAN STANLEY	0.05%	-	680	680	100.00%	316,000	Mar 31, 2023
ALLWORTH FINANCIAL LP	0.00%	-	1	1	100.00%	1,000	Mar 31, 2023
WELLS FARGO & COMPANY/MN	0.00%	-	64	64	100.00%	30,000	Mar 31, 2023
MORGAN STANLEY	-	-	-	-680	-100.00%	-	Mar 31, 2023
BLACKROCK INC.	-	-	-	-23,954	-100.00%	-	Mar 31, 2023
NORTHERN TRUST CORP	-	-	-	-1,734	-100.00%	-	Mar 31, 2023
STATE STREET CORP	-	-	-	-6,921	-100.00%	-	Mar 31, 2023
RENAISSANCE TECHNOLOGIES LLC	-	-	-	-3,169	-100.00%	-	Mar 31, 2023
ACADIAN ASSET MANAGEMENT LLC	-	-	-	-60,501	-100.00%	-	Mar 31, 2023
HRT FINANCIAL LP	-	-	-	-1,293	-100.00%	-	Mar 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)	-	-	-	-477	-100.00%	-	Mar 31, 2023

The largest Tenax Therapeutics shareholder by % of total assets is VIRTU FINANCIAL LLC. The company owns 84.36K shares of Tenax Therapeutics (TENX), representing 0.00% of its total assets.

Institutional Buyers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
CI PRIVATE WEALTH, LLC	13.62%	0.00%	191,460	191,460	100.00%	89,029,000	Mar 31, 2023
STATE STREET CORP	6.77%	-	95,122	95,122	100.00%	44,232,000	Mar 31, 2023
VIRTU FINANCIAL LLC	6.00%	0.00%	84,361	84,361	100.00%	39,000	Mar 31, 2023
VERITION FUND MANAGEMENT LLC	3.10%	0.00%	43,579	43,579	100.00%	20,264,000	Mar 31, 2023
TWO SIGMA SECURITIES, LLC	3.06%	0.00%	42,995	42,995	100.00%	19,993,000	Mar 31, 2023
BLACKROCK INC.	1.70%	-	23,922	23,922	100.00%	11,124,000	Mar 31, 2023
AVANTAX PLANNING PARTNERS, INC.	0.71%	0.00%	10,002	10,002	100.00%	4,651,000	Mar 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)	0.33%	0.00%	4,697	4,697	100.00%	2,000	Mar 31, 2023
MORGAN STANLEY	0.05%	-	680	680	100.00%	316,000	Mar 31, 2023
WELLS FARGO & COMPANY/MN	0.00%	-	64	64	100.00%	30,000	Mar 31, 2023
TUCKER ASSET MANAGEMENT LLC	0.00%	-	2	2	100.00%	1,000	Mar 31, 2023
ALLWORTH FINANCIAL LP	0.00%	-	1	1	100.00%	1,000	Mar 31, 2023
TUCKER ASSET MANAGEMENT LLC	-	-	-	-2	-100.00%	-	Mar 31, 2023
PNC FINANCIAL SERVICES GROUP, INC.	-	-	-	-10	-100.00%	-	Mar 31, 2023
WELLS FARGO & COMPANY/MN	-	-	-	-13	-100.00%	-	Mar 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)	-	-	-	-477	-100.00%	-	Mar 31, 2023
MORGAN STANLEY	-	-	-	-680	-100.00%	-	Mar 31, 2023
HRT FINANCIAL LP	-	-	-	-1,293	-100.00%	-	Mar 31, 2023
NORTHERN TRUST CORP	-	-	-	-1,734	-100.00%	-	Mar 31, 2023
GEODE CAPITAL MANAGEMENT, LLC	-	-	-	-2,561	-100.00%	-	Mar 31, 2023

As of Mar 31 2023, Tenax Therapeutics's largest institutional buyer is CI PRIVATE WEALTH, LLC. The company purchased 191.46K stocks of TENX, valued at $89.03M.

Institutional Sellers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
ACADIAN ASSET MANAGEMENT LLC	-	-	-	-60,501	-100.00%	-	Mar 31, 2023
BLACKROCK INC.	-	-	-	-23,954	-100.00%	-	Mar 31, 2023
VANGUARD GROUP INC	-	-	-	-8,691	-100.00%	-	Mar 31, 2023
UBS GROUP AG	-	-	-	-8,049	-100.00%	-	Mar 31, 2023
STATE STREET CORP	-	-	-	-6,921	-100.00%	-	Mar 31, 2023
TWO SIGMA SECURITIES, LLC	-	-	-	-3,387	-100.00%	-	Mar 31, 2023
RENAISSANCE TECHNOLOGIES LLC	-	-	-	-3,169	-100.00%	-	Mar 31, 2023
GEODE CAPITAL MANAGEMENT, LLC	-	-	-	-2,561	-100.00%	-	Mar 31, 2023
NORTHERN TRUST CORP	-	-	-	-1,734	-100.00%	-	Mar 31, 2023
HRT FINANCIAL LP	-	-	-	-1,293	-100.00%	-	Mar 31, 2023
MORGAN STANLEY	-	-	-	-680	-100.00%	-	Mar 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)	-	-	-	-477	-100.00%	-	Mar 31, 2023
WELLS FARGO & COMPANY/MN	-	-	-	-13	-100.00%	-	Mar 31, 2023
PNC FINANCIAL SERVICES GROUP, INC.	-	-	-	-10	-100.00%	-	Mar 31, 2023
TUCKER ASSET MANAGEMENT LLC	-	-	-	-2	-100.00%	-	Mar 31, 2023
ALLWORTH FINANCIAL LP	0.00%	-	1	1	100.00%	1,000	Mar 31, 2023
TUCKER ASSET MANAGEMENT LLC	0.00%	-	2	2	100.00%	1,000	Mar 31, 2023
WELLS FARGO & COMPANY/MN	0.00%	-	64	64	100.00%	30,000	Mar 31, 2023
MORGAN STANLEY	0.05%	-	680	680	100.00%	316,000	Mar 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)	0.33%	0.00%	4,697	4,697	100.00%	2,000	Mar 31, 2023

As of Mar 31 2023, Tenax Therapeutics's biggest institutional seller is ACADIAN ASSET MANAGEMENT LLC. The company sold -60.50K shares of TENX, valued at -.

Institutional New positions

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
CI PRIVATE WEALTH, LLC	13.62%	0.00%	191,460	191,460	100.00%	89,029,000	Mar 31, 2023
STATE STREET CORP	6.77%	-	95,122	95,122	100.00%	44,232,000	Mar 31, 2023
VIRTU FINANCIAL LLC	6.00%	0.00%	84,361	84,361	100.00%	39,000	Mar 31, 2023
VERITION FUND MANAGEMENT LLC	3.10%	0.00%	43,579	43,579	100.00%	20,264,000	Mar 31, 2023
TWO SIGMA SECURITIES, LLC	3.06%	0.00%	42,995	42,995	100.00%	19,993,000	Mar 31, 2023
BLACKROCK INC.	1.70%	-	23,922	23,922	100.00%	11,124,000	Mar 31, 2023
AVANTAX PLANNING PARTNERS, INC.	0.71%	0.00%	10,002	10,002	100.00%	4,651,000	Mar 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)	0.33%	0.00%	4,697	4,697	100.00%	2,000	Mar 31, 2023
MORGAN STANLEY	0.05%	-	680	680	100.00%	316,000	Mar 31, 2023
WELLS FARGO & COMPANY/MN	0.00%	-	64	64	100.00%	30,000	Mar 31, 2023
TUCKER ASSET MANAGEMENT LLC	0.00%	-	2	2	100.00%	1,000	Mar 31, 2023
ALLWORTH FINANCIAL LP	0.00%	-	1	1	100.00%	1,000	Mar 31, 2023

Tenax Therapeutics's largest new institutional shareholder by number of shares is CI PRIVATE WEALTH, LLC, purchased 191.46K shares, valued at $89.03M, as of undefined.

Institutional Sold Out

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
ACADIAN ASSET MANAGEMENT LLC	-	-	-	-60,501	-100.00%	-	Mar 31, 2023
BLACKROCK INC.	-	-	-	-23,954	-100.00%	-	Mar 31, 2023
VANGUARD GROUP INC	-	-	-	-8,691	-100.00%	-	Mar 31, 2023
UBS GROUP AG	-	-	-	-8,049	-100.00%	-	Mar 31, 2023
STATE STREET CORP	-	-	-	-6,921	-100.00%	-	Mar 31, 2023
TWO SIGMA SECURITIES, LLC	-	-	-	-3,387	-100.00%	-	Mar 31, 2023
RENAISSANCE TECHNOLOGIES LLC	-	-	-	-3,169	-100.00%	-	Mar 31, 2023
GEODE CAPITAL MANAGEMENT, LLC	-	-	-	-2,561	-100.00%	-	Mar 31, 2023
NORTHERN TRUST CORP	-	-	-	-1,734	-100.00%	-	Mar 31, 2023
HRT FINANCIAL LP	-	-	-	-1,293	-100.00%	-	Mar 31, 2023
MORGAN STANLEY	-	-	-	-680	-100.00%	-	Mar 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)	-	-	-	-477	-100.00%	-	Mar 31, 2023
WELLS FARGO & COMPANY/MN	-	-	-	-13	-100.00%	-	Mar 31, 2023
PNC FINANCIAL SERVICES GROUP, INC.	-	-	-	-10	-100.00%	-	Mar 31, 2023
TUCKER ASSET MANAGEMENT LLC	-	-	-	-2	-100.00%	-	Mar 31, 2023

Tenax Therapeutics's largest sold out institutional shareholder by shares sold is ACADIAN ASSET MANAGEMENT LLC, sold -60.50K shares, valued at -, as of undefined.

Tenax Therapeutics Mutual Fund Holders

Name	% Total Assets	Total Shares	Change Amount	Change %	Date
VANGUARD INDEX FUNDS	0.00%	372,092	363,401	4181.35%	Dec 31, 2023
FIDELITY CONCORD STREET TRUST	0.00%	148,118	-	-	Feb 29, 2024
VANGUARD INDEX FUNDS	0.00%	173,801	-	-	Dec 31, 2023
FIDELITY CONCORD STREET TRUST	0.00%	51,179	-	-	Feb 29, 2024
DFA INVESTMENT DIMENSIONS GROUP INC	0.00%	12,186	-	-	Jan 31, 2024
EQ ADVISORS TRUST	0.00%	2,134	-	-	Dec 31, 2023

Tenax Therapeutics's largest mutual fund holder by % of total assets is "VANGUARD INDEX FUNDS", owning 372.09K shares, compromising 0.00% of its total assets.

Tenax Therapeutics Institutional Ownership Trends

Institutional Holdings Trend

Date	Holdings	Change %
31 Mar, 23	1	-95.24%
31 Dec, 22	15	-21.05%
30 Sep, 22	19	26.67%
30 Jun, 22	15	-
31 Mar, 22	15	-6.25%
31 Dec, 21	16	14.29%
30 Sep, 21	14	-12.50%
30 Jun, 21	16	6.67%
31 Mar, 21	15	-6.25%
31 Dec, 20	16	6.67%
30 Sep, 20	15	-11.76%
30 Jun, 20	17	88.89%
31 Mar, 20	9	-10.00%
31 Dec, 19	10	-16.67%
30 Sep, 19	12	33.33%
30 Jun, 19	9	-
31 Mar, 19	9	-10.00%
31 Dec, 18	10	66.67%
30 Sep, 18	6	-25.00%
30 Jun, 18	8	14.29%
31 Mar, 18	7	-

As of 31 Mar 23, 1 institutions are holding Tenax Therapeutics's shares, representing a decrease of -95.24% compared to the previous quarter.

Shares Outstanding Trend

Date	Shares Outstanding	Change %
31 Mar, 23	-	-100.00%
31 Dec, 22	2,428,685	-66.57%
30 Sep, 22	7,265,177	4.85%
30 Jun, 22	6,928,902	-14.27%
31 Mar, 22	8,082,294	0.25%
31 Dec, 21	8,062,390	4.55%
30 Sep, 21	7,711,585	120.01%
30 Jun, 21	3,505,165	-7.67%
31 Mar, 21	3,796,316	12.40%
31 Dec, 20	3,377,498	-16.63%
30 Sep, 20	4,051,309	76.18%
30 Jun, 20	2,299,515	49.91%
31 Mar, 20	1,533,971	23.74%
31 Dec, 19	1,239,642	1.85%
30 Sep, 19	1,217,178	9.40%
30 Jun, 19	1,112,582	10.33%
31 Mar, 19	1,008,372	96.12%
31 Dec, 18	514,159	191.74%
30 Sep, 18	176,237	1.56%
30 Jun, 18	173,534	9.53%
31 Mar, 18	158,432	-

Tenax Therapeutics (TENX) has 0.00 shares outstanding as of 31 Mar 23, down -100.00% compared to the previous quarter.

Institutional Ownership Trend

Date	Ownership %	Change %
31 Mar, 23	-	-
31 Dec, 22	26.11%	0.43%
30 Sep, 22	78.11%	1.41%
30 Jun, 22	74.50%	0.99%
31 Mar, 22	86.90%	1.16%
31 Dec, 21	86.69%	1.26%
30 Sep, 21	82.91%	3.28%
30 Jun, 21	50.26%	1.70%
31 Mar, 21	54.43%	2.32%
31 Dec, 20	48.43%	1.44%
30 Sep, 20	58.09%	5.34%
30 Jun, 20	32.97%	6.82%
31 Mar, 20	21.99%	6.96%
31 Dec, 19	17.77%	5.84%
30 Sep, 19	17.45%	3.37%
30 Jun, 19	22.77%	5.35%
31 Mar, 19	20.63%	18.64%
31 Dec, 18	10.52%	80.90%
30 Sep, 18	3.61%	28.60%
30 Jun, 18	3.55%	33.79%
31 Mar, 18	3.24%	-

As of 31 Mar 23, Tenax Therapeutics is held by 0.00% institutional shareholders, representing a 0.00% growth compared to 31 Dec 22.

Institutional Increased Positions Trend

Date	Increased Positions	Change %
31 Mar, 23	-	-100.00%
31 Dec, 22	6	-45.45%
30 Sep, 22	11	120.00%
30 Jun, 22	5	66.67%
31 Mar, 22	3	-57.14%
31 Dec, 21	7	16.67%
30 Sep, 21	6	-25.00%
30 Jun, 21	8	60.00%
31 Mar, 21	5	-
31 Dec, 20	5	-16.67%
30 Sep, 20	6	-53.85%
30 Jun, 20	13	333.33%
31 Mar, 20	3	-25.00%
31 Dec, 19	4	-33.33%
30 Sep, 19	6	100.00%
30 Jun, 19	3	-25.00%
31 Mar, 19	4	-42.86%
31 Dec, 18	7	600.00%
30 Sep, 18	1	-80.00%
30 Jun, 18	5	-28.57%
31 Mar, 18	7	-

- institutional shareholders have increased their position in TENX stock as of 31 Mar 23 compared to 6 in the previous quarter (a -100.00% decrease).

Institutional Reduced Positions Trend

Date	Reduced Positions	Change %
31 Mar, 23	-	-100.00%
31 Dec, 22	4	300.00%
30 Sep, 22	1	-66.67%
30 Jun, 22	3	-25.00%
31 Mar, 22	4	100.00%
31 Dec, 21	2	-
30 Sep, 21	2	-50.00%
30 Jun, 21	4	33.33%
31 Mar, 21	3	-25.00%
31 Dec, 20	4	33.33%
30 Sep, 20	3	200.00%
30 Jun, 20	1	-66.67%
31 Mar, 20	3	-
31 Dec, 19	-	-
30 Sep, 19	-	-100.00%
30 Jun, 19	3	50.00%
31 Mar, 19	2	100.00%
31 Dec, 18	1	-
30 Sep, 18	1	-
30 Jun, 18	1	-
31 Mar, 18	-	-

- institutional shareholders have reduced their position in TENX stock as of 31 Mar 23 compared to 4 in the previous quarter (a -100.00% decrease).

All Institutional Ownership Trend Data

Date	Holdings	Change %	Shares Outstanding	Change %	Ownership %	Change %	Increased Positions	Change %	Reduced Positions	Change %
31 Mar, 23	1	-95.24%	-	-100.00%	-	-	-	-100.00%	-	-100.00%
31 Dec, 22	15	-21.05%	2,428,685	-66.57%	26.11%	0.43%	6	-45.45%	4	300.00%
30 Sep, 22	19	26.67%	7,265,177	4.85%	78.11%	1.41%	11	120.00%	1	-66.67%
30 Jun, 22	15	-	6,928,902	-14.27%	74.50%	0.99%	5	66.67%	3	-25.00%
31 Mar, 22	15	-6.25%	8,082,294	0.25%	86.90%	1.16%	3	-57.14%	4	100.00%
31 Dec, 21	16	14.29%	8,062,390	4.55%	86.69%	1.26%	7	16.67%	2	-
30 Sep, 21	14	-12.50%	7,711,585	120.01%	82.91%	3.28%	6	-25.00%	2	-50.00%
30 Jun, 21	16	6.67%	3,505,165	-7.67%	50.26%	1.70%	8	60.00%	4	33.33%
31 Mar, 21	15	-6.25%	3,796,316	12.40%	54.43%	2.32%	5	-	3	-25.00%
31 Dec, 20	16	6.67%	3,377,498	-16.63%	48.43%	1.44%	5	-16.67%	4	33.33%
30 Sep, 20	15	-11.76%	4,051,309	76.18%	58.09%	5.34%	6	-53.85%	3	200.00%
30 Jun, 20	17	88.89%	2,299,515	49.91%	32.97%	6.82%	13	333.33%	1	-66.67%
31 Mar, 20	9	-10.00%	1,533,971	23.74%	21.99%	6.96%	3	-25.00%	3	-
31 Dec, 19	10	-16.67%	1,239,642	1.85%	17.77%	5.84%	4	-33.33%	-	-
30 Sep, 19	12	33.33%	1,217,178	9.40%	17.45%	3.37%	6	100.00%	-	-100.00%
30 Jun, 19	9	-	1,112,582	10.33%	22.77%	5.35%	3	-25.00%	3	50.00%
31 Mar, 19	9	-10.00%	1,008,372	96.12%	20.63%	18.64%	4	-42.86%	2	100.00%
31 Dec, 18	10	66.67%	514,159	191.74%	10.52%	80.90%	7	600.00%	1	-
30 Sep, 18	6	-25.00%	176,237	1.56%	3.61%	28.60%	1	-80.00%	1	-
30 Jun, 18	8	14.29%	173,534	9.53%	3.55%	33.79%	5	-28.57%	1	-
31 Mar, 18	7	-	158,432	-	3.24%	-	7	-	-	-

Tenax Therapeutics Insider Shareholders Trades

Open Market Insider Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source

Open Market Insider Buys

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source

Insider Sells

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Jan 12, 2024	HOFFMAN LAWRENCE R	officer	Interim CFO		Sell	-	-	-	-
Sep 23, 2022	Rich Stuart	director, 10 percent owner, officer	Chief Medical Officer	G-Gift	Sell	1,909,585	-	-	424,347
Aug 12, 2022	Doogan Declan	director		G-Gift	Sell	567,871	-	-	-
May 19, 2022	Boyd Steven	director		D-Return	Sell	2,072,538	-	-	-
Apr 12, 2022	Almenoff June Sherie	director	-		Sell	-	-	-	-
Jan 31, 2022	Hunter Robyn	director	-		Sell	-	-	-	-

All Insider Owners Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Jan 12, 2024	HOFFMAN LAWRENCE R	officer	Interim CFO		Sell	-	-	-	-
Sep 23, 2022	Rich Stuart	director, 10 percent owner, officer	Chief Medical Officer	G-Gift	Buy	1,909,585	-	-	1,909,585
Sep 23, 2022	Rich Stuart	director, 10 percent owner, officer	Chief Medical Officer	G-Gift	Sell	1,909,585	-	-	424,347
Aug 12, 2022	Doogan Declan	director		G-Gift	Sell	567,871	-	-	-
Jun 10, 2022	Rich Stuart	director	Chief Medical Officer	A-Award	Buy	100,000	-	-	100,000
Jun 10, 2022	Rich Stuart	director, 10 percent owner, officer	Chief Medical Officer	A-Award	Buy	100,000	$0.62	$62.00K	100,000
Jun 10, 2022	PROEHL GERALD T	director		A-Award	Buy	5,000	-	-	5,000
Jun 10, 2022	PROEHL GERALD T	director	-	A-Award	Buy	5,000	$0.62	$3.10K	5,000
Jun 10, 2022	Hunter Robyn	director		A-Award	Buy	6,250	-	-	6,250
Jun 10, 2022	Hunter Robyn	director	-	A-Award	Buy	6,250	$0.62	$3.88K	6,250
Jun 10, 2022	Giordano Christopher Thomas	director	CEO	A-Award	Buy	200,000	-	-	200,000
Jun 10, 2022	Doogan Declan	director		A-Award	Buy	5,000	-	-	5,000
Jun 10, 2022	Davidson Michael H.	director		A-Award	Buy	5,000	-	-	5,000
Jun 10, 2022	Davidson Michael H.	director	-	A-Award	Buy	5,000	$0.62	$3.10K	5,000
Jun 10, 2022	Almenoff June Sherie	director		A-Award	Buy	5,000	-	-	5,000
Jun 10, 2022	Almenoff June Sherie	director	-	A-Award	Buy	5,000	$0.62	$3.10K	5,000
May 19, 2022	Boyd Steven	director		A-Award	Buy	10,596,027	-	-	10,596,027
May 19, 2022	Boyd Steven	director		D-Return	Sell	2,072,538	-	-	-
Apr 12, 2022	Almenoff June Sherie	director	-		Sell	-	-	-	-
Jan 31, 2022	Hunter Robyn	director	-		Sell	-	-	-	-

The last insider sell of Tenax Therapeutics's stock was made by HOFFMAN LAWRENCE R on Jan 12 2024, selling - shares at - per share (valued at -).

Tenax Therapeutics Insider Ownership Trends

All Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q1 2024	-	1	-
Q3 2022	-	1	-
Q2 2022	8	1	800.00%
Q1 2022	-	1	-
Q4 2021	2	3	66.67%
Q3 2021	3	1	300.00%
Q2 2021	8	4	200.00%
Q1 2021	5	5	100.00%
Q3 2020	26	4	650.00%
Q2 2020	5	-	-
Q1 2020	2	1	200.00%
Q2 2019	1	-	-
Q4 2018	-	1	-
Q3 2018	1	-	-
Q2 2018	5	-	-
Q1 2018	1	-	-
Q4 2017	3	1	300.00%
Q3 2017	1	-	-
Q2 2017	2	-	-
Q1 2017	1	1	100.00%

0 total buy trades, and 1 total sell trades (buy/sell ratio of 0.00%) were made by Tenax Therapeutics's insiders, as of Q1 2024.

Open Market Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q1 2024	-	-	-
Q3 2022	-	-	-
Q2 2022	-	-	-
Q1 2022	-	-	-
Q4 2021	-	-	-
Q3 2021	-	-	-
Q2 2021	-	-	-
Q1 2021	-	-	-
Q3 2020	26	-	-
Q2 2020	1	-	-
Q1 2020	-	-	-
Q2 2019	-	-	-
Q4 2018	-	-	-
Q3 2018	-	-	-
Q2 2018	-	-	-
Q1 2018	-	-	-
Q4 2017	2	1	200.00%
Q3 2017	-	-	-
Q2 2017	-	-	-
Q1 2017	-	-	-

As of Q1 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Tenax Therapeutics's stocks.

Tenax Therapeutics Peer Ownership

Ticker	Company
ZVSA	ZyVersa Therapeutics, Inc.
VRAX	Virax Biolabs Group Limited
QNRX	Quoin Pharmaceuticals, Ltd.
ENSC	Ensysce Biosciences, Inc.
UNCY	Unicycive Therapeutics, Inc.
BWV	Onconetix, Inc.
PXMD	PaxMedica, Inc. Common Stock
REVB	Revelation Biosciences, Inc.
WINT	Windtree Therapeutics, Inc.
NRBO	NeuroBo Pharmaceuticals, Inc.
CYTO	Altamira Therapeutics Ltd.
ADTX	Aditxt, Inc.
HILS	Tharimmune, Inc.
ALLR	Allarity Therapeutics, Inc.
DRMA	Dermata Therapeutics, Inc.
BXRX	Baudax Bio, Inc.
SONN	Sonnet BioTherapeutics Holdings, Inc.

TENX Ownership FAQ

Who Owns Tenax Therapeutics?

Tenax Therapeutics is owned by institutional shareholders (0%), insiders (0.36%), and public (0%). The largest institutional shareholder of Tenax Therapeutics is CI PRIVATE WEALTH, LLC (13.62% of total shares) and the top mutual fund owner is VANGUARD INDEX FUNDS (0.00% of total shares).

Who are the major institutional shareholders of Tenax Therapeutics?

Tenax Therapeutics's major institutional shareholders are CI PRIVATE WEALTH, LLC, STATE STREET CORP, VIRTU FINANCIAL LLC, VERITION FUND MANAGEMENT LLC, and TWO SIGMA SECURITIES, LLC. The top five shareholders own together 32.54% of the company's share outstanding.

How many Tenax Therapeutics shareholders are there?

As of Mar 2023, there are 1 institutional shareholders of Tenax Therapeutics.

What percentage of Tenax Therapeutics is owned by CI PRIVATE WEALTH, LLC?

CI PRIVATE WEALTH, LLC owns 191.46K shares of Tenax Therapeutics, representing 13.62% of the company's total shares outstanding, valued at $89.03M (as of Mar 2023).

What percentage of Tenax Therapeutics is owned by STATE STREET CORP?

As of Mar 2023, STATE STREET CORP holds 95.12K shares of Tenax Therapeutics (TENX), compromising 6.77% of the company, valued at $44.23M.

What percentage of Tenax Therapeutics is owned by VIRTU FINANCIAL LLC?

VIRTU FINANCIAL LLC is the third largest holder of Tenax Therapeutics. The company owns 84.36K of the company's shares outstanding (worth $39K).